Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_assertion type Assertion NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_head.
- NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_assertion description "[We genotyped 8 ERCC2 htSNPs for 129 unresectable NSCLC (stage IIIA, 12; stage III, 36; stage IV, 82) cases treated with first-line platinum-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_provenance.
- NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_assertion evidence source_evidence_literature NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_provenance.
- NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_assertion SIO_000772 22608006 NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_provenance.
- NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_assertion wasDerivedFrom befree-20150227 NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_provenance.
- NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_assertion wasGeneratedBy ECO_0000203 NP382034.RATl3PyN4blT9h3imPzOhvpfagPeR9w-s8ut2IuUMUBuA130_provenance.